Sutro Biopharma, Inc.
Sutro Biopharma, Inc. scores highest on Torque (93) and lowest on Price (0). Its PosiPenta is 39.16 out of 100, weaker than most similar companies.
On the Penta Grid this week, Sutro Biopharma, Inc. is Grid #568 of 837 in the Healthcare sector in United States, and Grid #2,969 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Sutro Biopharma, Inc. | 39.16 | 0 | 35 | 31 | 93 | 38 |
| OptimizeRx Corporation | 58.71 | 54 | 86 | 42 | 62 | 49 |
| Oramed Pharmaceuticals Inc. | 74.51 | 92 | 49 | 77 | 90 | 65 |
| Sionna Therapeutics, Inc. | 37.60 | 44 | 26 | 8 | 62 | 48 |
| ALX Oncology Holdings Inc. | 43.76 | 39 | 52 | 37 | 44 | 47 |
| Korro Bio, Inc. | 31.00 | 37 | 34 | 25 | 31 | 27 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.63 |
| P/B ratio | -1.76 |
EEarnings
| Trailing EPS | ₹-1636.67 |
| Forward EPS | ₹-588.42 |
NNitro
| Price | 1036.18 |
| 52-week high | 4153.25 |
| 52-week low | 677.21 |
| Fall from 52-week high | 75.1% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -0.12 |
AAnchor
| Beta (price swings) | 1.50 |
| Market cap | ₹1,718 Cr |
| Insider holding | 2.26% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Sutro Biopharma, Inc.'s PosiPenta score?
Sutro Biopharma, Inc.'s PosiPenta is 39.16 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Sutro Biopharma, Inc. stand on the Penta Grid?
On the Penta Grid this week, Sutro Biopharma, Inc. is Grid #568 of 837 in the Healthcare sector in United States, and Grid #2,969 of 4,000 in United States.
Which PosiPenta pillar is strongest for Sutro Biopharma, Inc.?
Torque (durability), with a score of 93 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Sutro Biopharma, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Sutro Biopharma, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.47 points, from 35.69 to 39.16.
PositoAI is for research and education only and is not investment advice.